FG
PGNY icon

Formula Growth’s Progyny PGNY Stock Holding History

Formula Growth’s Portfolio PGNY Stock Details PGNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,605
Closed -$3.34M – 120
2024
Q1 		$3.34M Sell
87,605
-22,262
-20% -$842K 1.07% 40
2023
Q4 		$4.08M Sell
109,867
-800
-0.7% -$26.9K 1.31% 16
2023
Q3 		$3.76M Sell
110,667
-895
-0.8% -$33.8K 1.28% 20
2023
Q2 		$4.39M Sell
111,562
-6,912
-6% -$249K 1.4% 18
2023
Q1 		$3.81M Buy
118,474
+16,800
+17% +$555K 1.23% 24
2022
Q4 		$3.17M Sell
101,674
-15,200
-13% -$550K 0.9% 46
2022
Q3 		$4.33M Buy
116,874
+1,000
+0.9% +$37.4K 1.24% 25
2022
Q2 		$3.37M Hold
115,874
– – 0.93% 42
2022
Q1 		$5.96M Sell
115,874
-2,249
-2% -$96.3K 1.12% 31
2021
Q4 		$5.95M Sell
118,123
-6,877
-6% -$385K 1.06% 32
2021
Q3 		$7M Hold
125,000
– – 1% 29
2021
Q2 		$7.38M Buy
+125,000
New +$7.02M 1.02% 28

Other funds holding PGNY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ONPI
Owls Nest Partners IA Chadds Ford, Pennsylvania $308M AUM 33.98% 1-Year Est. Return

Formula Growth's PGNY Position: Q2 2024 in Review

Formula Growth sold out of Progyny (PGNY) in Q2 2024, closing a stake of 87,605 shares — an estimated $3.34M sold.

Formula Growth first reported a position in PGNY in Q2 2021 and held it in 12 quarters. The position peaked at $7.38M in Q2 2021. 325 funds tracked by Wall St. Rank hold PGNY as of Q2 2024.

  • Formula Growth reported no remaining Progyny position as of Q2 2024 after selling out during the quarter.
  • Formula Growth sold 87,605 Progyny shares in Q2 2024, an estimated $3.34M.
  • Formula Growth first reported a position in Progyny in Q2 2021 and held it in 12 quarters.
  • Formula Growth's Progyny position peaked at $7.38M in Q2 2021.
  • 325 funds tracked by Wall St. Rank held Progyny as of Q2 2024.

Based on Formula Growth's 13F filing for Q2 2024, filed 13 Aug 2024.